Trial Profile
Pemetrexed plus Platinum as Adjuvant Therapy in Patients with Resected Lung Adenocarcinoma and Exploratory Biomarkers Analysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2015
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Pemetrexed (Primary)
- Indications Adenocarcinoma; Lung cancer
- Focus Therapeutic Use
- 19 Oct 2015 New trial record
- 09 Sep 2015 Results presented at the 16th World Conference on Lung Cancer.